Results 181 to 190 of about 44,548 (260)

Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes. [PDF]

Leukemia
Gagnon LL, Duminuco A, Stagno F, Sobas M, Fominykh M, Virchis A, Nicolini FE, Hildt J, Bentley H, Godfrey AL, Shih LY, Chee A, Mead A, Lewandowski K, Sobieralski P, Hannah G, Reyal Y, Cummin T, Piszcz J, Yip K, Frewin R, Narayanan S, Rahman D, Ajayi A, Cervi P, Byrne J, Taylor T, Lebowa W, Pavlu J, Arami S, Ceesay M, Chraniuk D, Delage R, Condorelli A, Santana C, Radia DH, de Lavallade H, Milojkovic D, Harrison C, Harrington P.   +39 more
europepmc   +1 more source

Erratum: Non-invasive detection of bone marrow fibrosis in myeloproliferative neoplasms using cell-free RNA. [PDF]

iScience
Saad M, Fuchs SNR, Schalla C, Götz K, Pritchard JE, Flosdorf N, Benabid A, Gleitz HFE, Leimkühler N, Dugourd A, Schneider RK.   +10 more
europepmc   +1 more source

An Uncommon Link: Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in the Setting of Myeloproliferative Neoplasms. [PDF]

Cureus
Sharma S, Khalid A, Yassa ME, Al Jaber E.   +3 more
europepmc   +1 more source

Clinical and disease characteristics from REVEAL at time of enrollment (baseline): Prospective observational study of patients with polycythemia vera in the United States [PDF]

, 2018
Boccia, Ralph V, Colucci, Philomena, Grunwald, Michael R, Mesa, Ruben, Oh, Stephen T, Paranagama, Dilan, Parasuraman, Shreekant, Stein, Brady L   +7 more
core   +1 more source

Impact of statin use on cardiovascular and hematologic outcomes among patients with myeloproliferative neoplasms. [PDF]

Blood Adv
Leiva O, Soo S, Liu OC, You V, Palmer A, Kahla J, Murtaza Y, Odenike O, Patel AA, DeCara JM, Dubielecka PM, Petersen M, Lee MH, How J, Hobbs G.   +14 more
europepmc   +1 more source

Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center. [PDF]

Mediterr J Hematol Infect Dis
Aydin MS, Korkmaz G, Pamukcuoglu M, Guner HR, Ceran F, Dagdas S, Ozet G.   +6 more
europepmc   +1 more source

Blood signals: from birth to disease and death

, 2014
Bowman, T., Flores-Figueroa, E., King, K., Kokkaliaris, K., Lessard, J., Trompouki, E., Will, B.   +6 more
core   +1 more source

Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML [PDF]

, 2013
et al,, Oh, Stephen T
core   +2 more sources

Unraveling the role of <i>TP53</i> mutations in myeloproliferative neoplasms: Molecular mechanisms of leukemic transformation. [PDF]

Hemasphere
da Silva-Benedito S, Bernardo PS, Martin JE, Marty C, Plo I, Antony-Debré I, Monte-Mór BDCR.   +6 more
europepmc   +1 more source

Outcomes of allogeneic transplantation in blast-phase myeloproliferative neoplasms: one-third achieve long-term survival. [PDF]

Bone Marrow Transplant
Barbullushi K, Gagelmann N, Rathje K, Badbaran A, Richter J, Schäfersküpper M, Marquard FE, Massoud R, Klyuchnikov E, Steiner N, Reichard M, Rudolph I, Heidenreich S, Niederwieser C, Lück C, Janson D, Wolschke C, Ayuk F, Kröger N.   +18 more
europepmc   +1 more source